Trial completion date • Trial primary completion date • Enrollment open • Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • MUC16 (Mucin 16, Cell Surface Associated)
|
HER-2 amplification • HER-2 L755S • HER-2 S310F • HER-2 V777L • HER-2 G778_P780dup • HER-2 A775
|
MSK-IMPACT
|
Kadcyla (ado-trastuzumab emtansine)